Comparative study on treatment methods of female pattern hair loss

Comparative study on treatment methods of female pattern hair loss: a randomized, controlled study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044015

Enrollment

Unknown

Registered

2021-03-06

Start date

2021-03-08

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female pattern hair loss

Interventions

first group:Minoxidil solution

second group:Minoxidil solution and spironolactone

third group:Minoxidil and laser hair cap

fourth group:Minoxidil and microneedle

fifth group:YuFa and microneedle

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-45 years female; 2.FPHL diagnosis is clear, Sinclair class for II, III; 3.No topical use of drugs with hair growth or other topical treatments within 1 month before treatment; 4.2 months before treatment without systematic use of drugs with hair growth effect; 5.Have good compliance, can regularly participate in the visit.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Insufficiency of heart, liver and kidney, anemia, low blood pressure or elevated blood potassium; 3. Other types of hair loss, such as alopecia areata, alopecia tinea capitis; 4. Scalp hair follicle atrophy so that no hair function; 5. Fail to take the medicine as required, unable to judge the efficacy or incomplete data; 6. Patients suffering from serious systemic diseases, endocrine or immune diseases and mental nervous system diseases; 7. There are problems in the microneedle area that are not suitable for perform; 8. Abnormal platelet count; 9. Allergic to the test drug and its ingredients; 10. Investigator participating in other clinical trials; 11. The investigator considers it inappropriate to participate in the study.

Design outcomes

Primary

Measure	Time frame
global photographic evaluation;the women's androgenetic alopecia Quality of Life questionnaire, WAA-QOL;Patient Satisfaction score;UBM number of follicles;Diameter of the largest follicle;Hair density;Terminal hair;Hair diameter;Single cell sequencing;Folliscope total hair;UBM epidermal thickness;UBM dermic thickness;Sebum level;Hair shedding score;	—

Countries

China

Contacts

Public ContactZhuo Fenglin

Beijing Friendship Hospital affiliated to Capital Medical University

zflsunny@hotmail.com+86 15910895068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026